Margitta T. Kampman

Tromso, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Amyotrophic lateral sclerosis caused by the C9orf72 expansion in Norway - prevalence, ancestry, clinical characteristics and sociodemographic status.

Amyotrophic lateral sclerosis caused by the C9orf72 expansion in Norway - prevalence, ancestry, clinical characteristics and sociodemographic status.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: September 24, 2024

Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis.

Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis.

Journal: Brain communications

Published: September 21, 2023

Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.

Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.

Journal: Neuroepidemiology

Published: March 15, 2022

Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study.

Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study.

Journal: Multiple sclerosis and related disorders

Published: April 07, 2021

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 02, 2019

Vitamin D supplementation and neurofilament light chain in multiple sclerosis.

Vitamin D supplementation and neurofilament light chain in multiple sclerosis.

Journal: Acta neurologica Scandinavica

Published: August 04, 2018

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Journal: BMC neurology

Published: November 18, 2016

Full Implementation of Screening for Nutritional Risk and Dysphagia in an Acute Stroke Unit: A Clinical Audit.

Full Implementation of Screening for Nutritional Risk and Dysphagia in an Acute Stroke Unit: A Clinical Audit.

Journal: The Neurohospitalist

Published: October 14, 2016

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 25, 2016

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 22, 2016

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 22, 2016

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Journal: Journal of neurology

Published: July 17, 2015

Showing 1-12 of 36

Last Updated: 09/26/2026